Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019

11.15.2019 By Ecaterina Craciun

Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result reported in 2018, and a net profit of RON21.5 million, nearly 2% higher on the year, according to the stock market data.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Antibiotice Iasi
, sales
, net profit